Trial Outcomes & Findings for Propofol Versus Sevoflurane Recovery After Gynecological Surgery (NCT NCT01755234)

NCT ID: NCT01755234

Last Updated: 2016-03-14

Results Overview

Quality of recovery score 24 hours after the surgical procedure.Score of 40 is poor recovery and a score of 200 is good recovery.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

90 participants

Primary outcome timeframe

24 hours after the surgical procedure

Results posted on

2016-03-14

Participant Flow

Subjects were recruited 12/2012-04/2014. 101 subjects were assessed for eligibility, 4 did not meet inclusion criteria and 7 declined to participate. 90 subjects were randomized.

Participant milestones

Participant milestones
Measure
Sevoflurane
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Overall Study
STARTED
45
45
Overall Study
COMPLETED
30
37
Overall Study
NOT COMPLETED
15
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Sevoflurane
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Overall Study
Lost to Follow-up
11
6
Overall Study
Change in surgical case
2
1
Overall Study
case cancelled
1
0
Overall Study
Withdrawal by Subject
0
1
Overall Study
unblinded
1
0

Baseline Characteristics

Propofol Versus Sevoflurane Recovery After Gynecological Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sevoflurane
n=45 Participants
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
n=45 Participants
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Total
n=90 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
45 Participants
n=5 Participants
45 Participants
n=7 Participants
90 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
45 Participants
n=5 Participants
45 Participants
n=7 Participants
90 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
45 participants
n=5 Participants
45 participants
n=7 Participants
90 participants
n=5 Participants

PRIMARY outcome

Timeframe: 24 hours after the surgical procedure

Quality of recovery score 24 hours after the surgical procedure.Score of 40 is poor recovery and a score of 200 is good recovery.

Outcome measures

Outcome measures
Measure
Sevoflurane
n=30 Participants
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
n=37 Participants
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Quality of Recovery Score 24 Hours Post Operative
175 units on a scale
Interval 163.0 to 181.0
176 units on a scale
Interval 163.0 to 184.0

SECONDARY outcome

Timeframe: PACU admission to discharge

Total opioid use in the post operative care unit (Mg of morphine equivalents)

Outcome measures

Outcome measures
Measure
Sevoflurane
n=30 Participants
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
n=37 Participants
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Mg of Morphine Equivalents (IV)
9 miligrams of morphine equivalents
Interval 4.0 to 17.0
9.4 miligrams of morphine equivalents
Interval 5.0 to 17.0

SECONDARY outcome

Timeframe: Time in the post anesthesia care unit

Numeric rating scale for pain on a scale of 0-10 (0 is no pain and 10 is high pain) versus time curve in the post anesthesia care unit ( score \* min). A higher value indicates more pain and time in the Post Anesthesia Care Unit. The range is 0 pain to x time in minutes x 1 hour to 5 hour ( 60-300 minutes) . The pain scores were collected at 15 minute intervals from the time of admission to the PACU. The area under the NRS pain scale versus time curve was calculated using the trapezoidal method as an indicator of pain burden during early recovery (Graph Pad Prism ver 5.03, Graph Pad Software INC.

Outcome measures

Outcome measures
Measure
Sevoflurane
n=30 Participants
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
n=37 Participants
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Pain in Post Anesthesia Care Unit
270 Pain Score * minutes in PACU
Interval 195.0 to 330.0
240 Pain Score * minutes in PACU
Interval 165.0 to 330.0

SECONDARY outcome

Timeframe: Discharge from PACU to 24 hours post operative after PACU discharge.

Opioid use in mg of morphine equivalents from discharge from the post anesthesia care unit to 24 hours after PACU discharge.

Outcome measures

Outcome measures
Measure
Sevoflurane
n=30 Participants
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
n=37 Participants
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Opioid Use Discharge From Post Anesthesia Care Unit to 24 Hours After PACU Discharge.
30 mg morphine equivalents
Interval 10.0 to 40.0
25 mg morphine equivalents
Interval 0.0 to 40.0

Adverse Events

Sevoflurane

Serious events: 0 serious events
Other events: 13 other events
Deaths: 0 deaths

Propofol

Serious events: 0 serious events
Other events: 11 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Sevoflurane
n=30 participants at risk
Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube) Sevoflurane: Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube
Propofol
n=37 participants at risk
Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60 Propofol: Propofol administered via intravenous catheter at an initial rate of 1.0 -2.0 mg/kg then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60
Gastrointestinal disorders
Nausea
43.3%
13/30 • Number of events 13 • Time in the post anesthesia care unit.
Nausea experienced in the post anesthesia care unit
29.7%
11/37 • Number of events 11 • Time in the post anesthesia care unit.
Nausea experienced in the post anesthesia care unit
Gastrointestinal disorders
Vomiting
10.0%
3/30 • Number of events 3 • Time in the post anesthesia care unit.
Nausea experienced in the post anesthesia care unit
2.7%
1/37 • Number of events 1 • Time in the post anesthesia care unit.
Nausea experienced in the post anesthesia care unit

Additional Information

Gildasio De Oliveira

Northwestern University

Phone: 312-695-4858

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place